Overall, Walgreens stock looks undervalued at its current levels of around $18, irrespective of the Boots deal. It currently ...
Walgreens Boots Alliance (NYSE: WBA) stock price has become a toxic wasteland. It crashed to a low of $17 on Wednesday, much ...
Walgreens Boots Alliance Inc’s (NASDAQ: WBA) second quarter fiscal year 2024 sales increased 6.3% Y/Y to $37.1 billion, up ...
Walgreens is conducting a new round of layoffs, the latest in a string of job cuts over the past year as the retail pharmacy giant aims to slash costs. Walgreens spokesman Fraser Engerman said the ...
Walgreens, Lumen, Truist and Verizon are among the companies with the largest impairments in the past year.
Cigna reported a $300 million first quarter loss as the company grapples with the loss in value of its investment in ...
Walgreens Boots Alliance is in the process of contacting potential buyers to sell its UK-based Boots drugstore chain.
In late 2022, Cigna's Evernorth unit made a $2.5 billion investment in VillageMD, and gained a minority stake in the primary ...
It’s tiny, squishy, chewy. It’s shaped like a cute baby mango and GenZers have gone crazy over it. Walgreens can’t keep it in stock. For the beleaguered drugstore chain, the odd “Gummy ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Walgreens is launching Walgreens Specialty Pharmacy, a $24 billion business that integrates a new pharmacy equipped to handle gene and cell therapies with its existing pharmacy assets including ...
Cigna disclosed it took a $1.8 billion non-cash charge on an impairment of its stake in the VillageMD clinic chain that’s ...